Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 232.00
Bid: 231.00
Ask: 233.00
Change: 1.00 (0.43%)
Spread: 2.00 (0.866%)
Open: 230.00
High: 232.00
Low: 230.00
Prev. Close: 231.00
DATA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update, Dividend Deferral and AGM

21 Apr 2020 07:00

RNS Number : 2610K
GlobalData PLC
21 April 2020
 

21 April 2020

GlobalData Plc

 

COVID-19 Update, Dividend Deferral and AGM

 

GlobalData PLC, the global provider of data, analytics, and insights comments on current trading and the wider impact of the evolving COVID-19 pandemic.

 

COVID-19 Update

 

GlobalData plc (the "Company") continues to closely monitor the evolving COVID-19 (coronavirus) situation and its impact on its business. GlobalData's priority remains the health and safety of our colleagues, our clients and our wider stakeholder group, whilst continuing to operate and provide our clients with real-time data, analytics, and insight that helps them navigate through these uncertain times.

 

As a business, we are following all relevant government guidelines in the countries where we operate and, given the agile and digital nature of our business we have been able to transition smoothly to a 'work from home' model in relatively short order and have not needed to furlough any employees or rely on government support. We recognise that many of our subscription clients are facing real challenges in their markets and are pleased that we have been able to offer a continued service, without any disruption, as well as developing a significant amount of COVID-19 specific content that is giving our clients unique insights into their sectors and geographies, at a time when they need it the most. We have also been active in delivering free Covid-19 content through our news sites, which is helping a wider audience understand their markets and the broader economic and health impacts of the pandemic. The development and deployment of this content has been achieved in a very short time period and is a good demonstration of our agile centralised operating model.

 

For our colleagues, we are actively ensuring that they have a strong and stable digital platform, which enables them to continue to perform in their roles and keep in touch. We are very focused on ensuring that our teams are coping with the challenges that working from home brings and offering the support and flexibility required. We are sending out regular internal communications, including employee surveys focused around well-being, mental health and employee satisfaction, as well as holding regular information sessions to keep our colleagues up to date with company news and initiatives.

 

Together as a business, our colleagues have continued to support our nominated charities for 2020, but we are also pleased to have chosen an additional eight charity partners in our local communities across the globe who are working on specific COVID-19 causes. To date we have raised over £100,000 and we are committed to continue to support our global communities through these difficult times.

 

With a high proportion of recurring revenue and broad sectorial diversification, our business model is resilient and renewal rates have been strong through the first quarter of the current financial year. Over 75% of the Group's revenue derives from recurring subscriptions, so our revenue therefore remains largely unaffected since the onset of the COVID-19 pandemic and we continue to have good visibility for the remainder of the year. As a result of COVID-19, some Events revenue has been deferred into the second half of 2020. Revenue from Events accounts for less than 10% of the Group.

 

Dividend Deferral

 

Although we have a resilient business model, we are aware that we are in unprecedented and very uncertain times. As a management team we are very focused on costs and our cash flow and consequently we have taken measures to scale back our planned sales team recruitment as well as postponing filling a number of open positions. We have a strong balance sheet, with good cash reserves and working capital along with financing arrangements that give us ample liquidity. However, we have taken the decision to delay the payment of the final dividend for the year ended 31 December 2019 by thirty business days to 9 June, which is within sixty business days of the record date of 27 March 2020 to allow us additional time to continue to assess the full impact of COVID-19, as allowed under revised LSE guidance.

 

AGM

 

In light of the COVID-19 outbreak and the enhanced restrictions imposed by the UK Government on 23 March 2020, shareholders will not be permitted to attend our Annual General Meeting, which will be held today at 10.00am, in person. This will safeguard our shareholders' and employees' health. Instead, shareholders can attend the meeting by joining it electronically in accordance with the instructions in the Notice of Meeting. If you are interested in this option, please call 020 7936 6400 in order to make the necessary arrangements.

 

 

ENQUIRIES:

 

GlobalData Plc

 

 

0207 936 6400

Mike Danson, Chief Executive Officer

Graham Lilley, Chief Financial Officer

N+1 Singer

0207 496 3000

James Maxwell

Justin McKeegan

 

Hudson Sandler

0207 796 4133

Nick Lyon

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGZGZDNGMGGZM
Date   Source Headline
28th Feb 20227:00 amRNSFinal Year Results
24th Feb 20227:00 amRNSHolding(s) in Company
14th Jan 20224:43 pmRNSPDMR Notification
10th Jan 20227:00 amRNSUpdate on FY21 performance and Capital Markets Day
15th Dec 20217:00 amRNSAcquisition of Automotive and Agribusiness Assets
9th Sep 20217:00 amRNSAcquisition of Life Sciences business
28th Jul 20219:09 amRNSPDMR Notification
26th Jul 20217:00 amRNSUnaudited interim report
2nd Jul 202112:27 pmRNSInterim Accounts
24th Jun 202110:37 amRNSBoard Change
1st Jun 20214:26 pmRNSPDMR Dealing
30th Apr 20217:00 amRNSBoard Change
20th Apr 202110:56 amRNSResults of AGM
26th Mar 20217:00 amRNSNotice of AGM and the proposed appointment of NED
26th Mar 20217:00 amRNSInterim Accounts
15th Mar 20217:00 amRNSAnnual Report
1st Mar 20217:01 amRNSBoard Changes
1st Mar 20217:00 amRNSFinal Results For The Year Ended 31 December 2020
12th Feb 20214:12 pmRNSHolding(s) in Company
18th Jan 20219:17 amRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSBoard Changes
21st Dec 20209:49 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSAppointment of Nomad and Broker
25th Nov 20207:00 amRNSTrading Update
9th Oct 20203:47 pmRNSTransfer of Shares out of Treasury
1st Sep 202012:16 pmRNSHolding(s) in Company
21st Aug 20208:55 amRNSAppointment of Joint Corporate Broker
27th Jul 20207:00 amRNSUnaudited Interim Report
21st May 20204:10 pmRNSEmployee Share Options and PDMR Dealing
19th May 20201:06 pmRNSIncreased Banking Facilities
21st Apr 202011:05 amRNSResults of AGM
21st Apr 20207:00 amRNSCOVID-19 Update, Dividend Deferral and AGM
27th Mar 202011:55 amRNSNotice of AGM
3rd Mar 20207:45 amRNSAnnual Report and Accounts
24th Feb 20207:00 amRNSFinal Results For The Year Ended 31 December 2019
16th Jan 20207:00 amRNSUpdate on Directorate Change
30th Oct 201910:59 amRNSHolding(s) in Company
3rd Oct 20197:00 amRNSDirectorate Change
29th Jul 20197:00 amRNSUnaudited Interim Report
19th Jul 20197:00 amRNSNotice of Results
23rd May 20197:00 amRNSNotice of Capital Markets Day
26th Apr 201912:57 pmRNSDirector/PDMR Dealings
23rd Apr 20194:20 pmRNSResults of AGM
28th Mar 20197:00 amRNSAnnual Report and Accounts and Notice of AGM
11th Mar 201911:41 amRNSPDMR Dealing
25th Feb 20197:00 amRNSFinal Results For The Year Ended 31 December 2018
17th Oct 20182:47 pmRNSHolding(s) in Company
30th Jul 20187:00 amRNSUnaudited Interim Report
4th May 20181:20 pmRNSDirector/PDMR Shareholding
30th Apr 20182:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.